193 related articles for article (PubMed ID: 35221982)
1.
Xu X; Ruan W; Liu F; Gai Y; Liu Q; Su Y; Liang Z; Sun X; Lan X
Front Aging Neurosci; 2021; 13():789054. PubMed ID: 35221982
[TBL] [Abstract][Full Text] [Related]
2. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
3. Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [
Zhang H; Wang M; Lu J; Bao W; Li L; Jiang J; Zuo C;
Front Neurosci; 2021; 15():598234. PubMed ID: 34234637
[TBL] [Abstract][Full Text] [Related]
4. Associations of [
Lu J; Bao W; Li M; Li L; Zhang Z; Alberts I; Brendel M; Cumming P; Lu H; Xiao Z; Zuo C; Guan Y; Zhao Q; Rominger A
Front Neurosci; 2020; 14():604. PubMed ID: 32694971
[TBL] [Abstract][Full Text] [Related]
5. Tau PET With
Huang CC; Hsiao IT; Huang CY; Weng YC; Huang KL; Liu CH; Chang TY; Wu HC; Yen TC; Lin KJ
Front Neurol; 2019; 10():503. PubMed ID: 31191427
[No Abstract] [Full Text] [Related]
6. The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer Disease.
Hsu JL; Lin KJ; Hsiao IT; Huang KL; Liu CH; Wu HC; Weng YC; Huang CY; Chang CC; Yen TC; Higuchi M; Jang MK; Huang CC
Clin Nucl Med; 2020 Oct; 45(10):747-756. PubMed ID: 32701794
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer's Disease.
Qiao Z; Wang G; Zhao X; Wang K; Fan D; Chen Q; Ai L
Front Aging Neurosci; 2022; 14():841942. PubMed ID: 35663582
[TBL] [Abstract][Full Text] [Related]
8. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using
Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y;
J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830
[TBL] [Abstract][Full Text] [Related]
9. Tau PET imaging with
Mueller A; Bullich S; Barret O; Madonia J; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
J Nucl Med; 2020 Jun; 61(6):911-919. PubMed ID: 31712323
[No Abstract] [Full Text] [Related]
10. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
[TBL] [Abstract][Full Text] [Related]
11. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [
Wang Y; Cai L; Zhou K; Cui M; Yao S
Front Bioeng Biotechnol; 2021; 9():812818. PubMed ID: 35223820
[No Abstract] [Full Text] [Related]
13. The Evaluation of Tau Deposition with [
Jantarato A; Vachatimanont S; Boonkawin N; Yaset S; Kunawudhi A; Promteangtrong C; Assanasen J; Mahanonda N; Chotipanich C
Mol Imaging; 2021; 2021():6640054. PubMed ID: 34381315
[TBL] [Abstract][Full Text] [Related]
14. Visual reading for [
Lin HC; Lin KJ; Huang KL; Chen SH; Ho TY; Huang CC; Hsu JL; Chang CC; Hsiao IT
Front Neurosci; 2023; 17():1148054. PubMed ID: 37250400
[TBL] [Abstract][Full Text] [Related]
15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
16. In Vivo
Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J
Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301
[TBL] [Abstract][Full Text] [Related]
17. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
18. Baseline [
Teng E; Manser PT; Sanabria Bohorquez S; Wildsmith KR; Pickthorn K; Baker SL; Ward M; Kerchner GA; Weimer RM
Alzheimers Res Ther; 2021 Dec; 13(1):196. PubMed ID: 34852837
[TBL] [Abstract][Full Text] [Related]
19. Functional Abnormality Associated With Tau Deposition in Alzheimer's Disease - A Hybrid Positron Emission Tomography/MRI Study.
Fu L; Zhou Z; Liu L; Zhang J; Xie H; Zhang X; Zhu M; Wang R
Front Aging Neurosci; 2021; 13():758053. PubMed ID: 34721001
[No Abstract] [Full Text] [Related]
20. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
